David Gill

David Gill

Direktor/Vorstandsmitglied bei EVOLUS, INC.

Vermögen: 271 112 $ am 31.05.2026

71 Jahre
Health Technology
Technology Services
Health Services

Profil

David Neil Gill is currently Independent Director at Evolus, Inc. since 2018; Director at The Alfred E.
Mann Foundation For Scientific Research, Bioretec Ltd. starting 2026, Bridge to Life Ltd., Allucent LLC, and RapidPulse, Inc.; Independent Non-Executive Director at Telix Pharmaceuticals Ltd. starting 2026; and Chief Financial Officer at Perspectum Group Ltd. since 2021.
Former roles include Chairman at Melinta Therapeutics, Inc. from 2019 to 2020; Independent Director at STRATA Skin Sciences, Inc. from 2018 to 2020; Independent Director at Histogenics Corp.
from 2015 to 2019; Independent Director at Cempra, Inc. from 2012 to 2020; Independent Director at Strongbridge Biopharma Plc from 2019 to 2021; Independent Director at Y-mAbs Therapeutics, Inc. from 2017 to 2025; Director at LeMaitre Vascular, Inc. from 2006 to 2008; Director at IsoTis OrthoBiologics, Inc. from 2006 to 2009; Chief Operating Officer at Novoste Corp.
from 1996 to 2000; President & Chief Operating Officer at Interland, Inc. from 2000 to 2001; Chief Financial Officer & Senior Vice President at CTI Molecular Imaging, Inc. from 2002 to 2005; President, Chief Operating & Financial Officer at EndoChoice, Inc. in 2016; Chief Financial Officer at TransEnterix, Inc. from 2009 to 2011; Chief Financial Officer at Syneos Health NC LLC from 2011 to 2013; Chief Financial Officer & Treasurer at NxStage Medical, Inc. from 2005 to 2006; Chief Financial Officer at INC Research Holdings, Inc. from 2011 to 2013; Chief Financial Officer at Perspectum Ltd. in 2021; Director at Calypso Medical Technologies, Inc. from 2000 to 2012; and Director at several other companies including IdleAire Technologies Corp., Cempra Pharmaceuticals, Inc., Novum Medical, Inc., EOS Imaging SA, and Azanta A. Education includes undergraduate studies at Wake Forest University and an MBA from Emory University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
17.04.2026 41.328 ( 0,06 % ) 271 112 $ 31.05.2026

Aktive Positionen von David Gill

UnternehmenPositionBeginn
BIORETEC OY Direktor/Vorstandsmitglied 08.05.2026
TELIX PHARMACEUTICALS LIMITED Direktor/Vorstandsmitglied 11.05.2026
EVOLUS, INC. Direktor/Vorstandsmitglied 12.02.2018
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Finanzdirektor/CFO 09.07.2021
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von David Gill

UnternehmenPositionEnde
YMAS THER Direktor/Vorstandsmitglied 16.09.2025
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von David Gill im Detail an

Ausbildung von David Gill

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

60

Beziehungen ersten Grades

36

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen36

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Producer Manufacturing

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Miscellaneous

Dornier Medical Systems, Inc.

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Technology Services

  1. Börse
  2. Insiders
  3. David Gill
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT